Filing Details

Accession Number:
0001209191-14-032573
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-05-09 14:36:23
Reporting Period:
2014-05-07
Filing Date:
2014-05-09
Accepted Time:
2014-05-09 14:36:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1178253 Scynexis Inc SCYX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1604069 Genavent F.c.p.r. 90 Boulevard Pasteur
Cs 21564
Paris Cedex 15 I0 75730
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-05-07 5,251 $0.20 5,251 No 4 X Direct
Common Stock Acquisiton 2014-05-07 5,251 $0.20 10,502 No 4 X Direct
Common Stock Acquisiton 2014-05-07 3,501 $0.20 14,003 No 4 X Direct
Common Stock Acquisiton 2014-05-07 53,112 $0.00 67,115 No 4 C Direct
Common Stock Acquisiton 2014-05-07 96,921 $0.00 164,036 No 4 C Direct
Common Stock Acquisiton 2014-05-07 46,824 $0.00 210,860 No 4 C Direct
Common Stock Acquisiton 2014-05-07 16,738 $0.00 227,598 No 4 C Direct
Common Stock Acquisiton 2014-05-07 10,000 $10.00 237,598 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 X Direct
No 4 X Direct
No 4 X Direct
No 4 C Direct
No 4 C Direct
No 4 C Direct
No 4 C Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Warrant (right to buy) Disposition 2014-05-07 5,251 $0.00 5,251 $0.20
Common Stock Common Stock Warrant (right to buy) Disposition 2014-05-07 5,251 $0.00 5,251 $0.20
Common Stock Common Stock Warrant (right to buy) Disposition 2014-05-07 3,501 $0.00 3,501 $0.20
Common Stock Series B Preferred Stock Disposition 2014-05-07 188,679 $0.00 53,112 $0.00
Common Stock Series C Preferred Stock Disposition 2014-05-07 342,726 $0.00 96,921 $0.00
Common Stock Series D-1 Preferred Stock Disposition 2014-05-07 955,215 $0.00 46,824 $0.00
Common Stock Series D-2 Preferred Stock Disposition 2014-05-07 341,456 $0.00 16,738 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2011-12-07 2016-12-06 No 4 X Direct
0 2012-05-15 2017-05-14 No 4 X Direct
0 2013-12-11 2018-12-10 No 4 X Direct
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
Footnotes
  1. Upon closing of the Issuer's initial public offering, each share of Series B Preferred Stock converted automatically into shares of common stock of the Issuer on a 1-for-3.536 basis, and had no expiration date.
  2. Upon closing of the Issuer's initial public offering, each share of Series C Preferred Stock converted automatically into shares of common stock of the Issuer on a 1-for-3.536 basis, and had no expiration date.
  3. Upon closing of the Issuer's initial public offering, each share of Series D-1 Preferred Stock converted automatically into shares of common stock of the Issuer on a 1-for-20.4 basis, and had no expiration date.
  4. Upon closing of the Issuer's initial public offering, each share of Series D-2 Preferred Stock converted automatically into shares of common stock of the Issuer on a 1-for-20.4 basis, and had no expiration date.